Wengrovitz Mark MD is categorized under Internal Medicine Doctors in San Antonio, TX and active since 2010.
Wengrovitz Mark MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Mark Wengrovitz at the company’s single location by writing to 4330 Medical Drive # 120, San Antonio, Texas TX 78229 or by phoning (210) 614-7414. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Wengrovitz Mark MD |
| Contact Person: | Mark Wengrovitz |
| Address: | 4330 Medical Drive # 120, San Antonio, Texas 78229 |
| Phone Number: | (210) 614-7414 |
| Website Address: | pvasatx.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Wengrovitz Mark MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Mark Wengrovitz for inquiries that concern Wengrovitz Mark MD by calling the company number (210) 614-7414, as your correspondence is most welcome. Additionally, the physical location of the single location of Wengrovitz Mark MD can be found at the coordinates 29.51094,-98.5708 as well as the street address 4330 Medical Drive # 120 in San Antonio, Texas 78229.
For its online presence, you may visit Wengrovitz Mark MD’s website at pvasatx.com and engage with its social media outlets through on Twitter and on Facebook.